Cargando…
Alvimopan Addition to a Standard Perioperative Recovery Pathway
BACKGROUND AND OBJECTIVES: Alvimopan, a peripherally acting mu-opioid receptor antagonist, decreased time to gastrointestinal recovery and hospital length of stay in open bowel resection patients in Phase 3 trials. However, the benefit in laparoscopic colectomy patients remains unclear. METHODS: A r...
Autores principales: | Itawi, Edward A., Savoie, Lisa M., Hanna, Amy J., Apostolides, George Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Laparoendoscopic Surgeons
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340958/ https://www.ncbi.nlm.nih.gov/pubmed/22643504 http://dx.doi.org/10.4293/108680811X13176785204076 |
Ejemplares similares
-
Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy
por: Hamilton, Zach, et al.
Publicado: (2015) -
Delayed gastrointestinal recovery after abdominal operation – role of alvimopan
por: Berger, Nicholas G, et al.
Publicado: (2015) -
Management of postoperative ileus: focus on alvimopan
por: Marderstein, Eric L, et al.
Publicado: (2008) -
Alvimopan: A cost–effective tool to decrease cystectomy length of stay
por: Manger, Jules Powers, et al.
Publicado: (2014) -
Prevention of Paralytic Ileus Utilizing Alvimopan Following Spine Surgery
por: Shah, Kalpit N., et al.
Publicado: (2015)